A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
Say “ultrasound,” and most people think of cloudlike images of a baby’s heart, limbs or face inside the mother’s womb. But the ultrasound is evolving into broader uses, earning it the nickname of “stethoscope of the 21st century.” The Virginia-Pilot